miR-379-5p通过准UBE2E3无素结合酶来影响乳腺癌细胞的行为
Araya K Schroder1, Conor J Loy1, Fernanda Aiala1
1Department of Biology, Denison University, Granville, Ohio, United States of America.
PloS one
|December 2, 2024
概括
微RNAs (miRNAs) 调节癌症中的基因表达. 这项研究确定UBE2E3是miR-379-5p的直接标,揭示了乳腺癌对细胞活力,增殖和细胞亡的复杂影响.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 微RNAs (miRNAs) 是基因表达的关键调节者,在癌症发展中起着重要作用.
- 在各种人类癌症中观察到miR-379-5p的下调,包括乳腺癌和膀癌.
- 导致瘤发生的miR-379-5p的特定mRNA点在很大程度上仍未确定.
研究的目的:
- 为了确定一个由miR-379-5p调节的基因,当miR-379-5p下调时可能促进癌症的发展.
- 研究miR-379-5p/UBE2E3相互作用对癌症相关的细胞行为的功能后果.
主要方法:
- 生物信息学分析以预测潜在的miRNA目标.
- 转染miRNA模仿和记者基因测试以验证直接向.
- 细胞活力,增殖和亡测定以评估功能影响.
主要成果:
- 生物信息学分析发现UBE2E3是miR-379-5p.p的潜在目标.
- miR-379-5p模仿传染减少了乳腺细胞中的UBE2E3mRNA和蛋白质水平.
- 路西法酶记者测定证实了miR-379-5p与UBE2E3 3'UTR的直接结合.
- 两种miR-379-5p模仿和UBE2E3沉默都降低了细胞活力;UBE2E3沉默增加了增殖和亡.
结论:
- 在乳腺细胞中,UBE2E3是miR-379-5p的直接目标.
- miR-379-5p通常会抑制乳腺细胞的活力和增殖.
- 沉默UBE2E3具有复杂的效果,促进增殖和亡,这表明在癌症发展中具有多方面的作用.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Destabilization of Microtubules
2.6K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


